Please login to the form below

Not currently logged in
Email:
Password:

sarcoma

This page shows the latest sarcoma news and features for those working in and with pharma, biotech and healthcare.

Nanobiotix signs €40m deal with the EIB

Nanobiotix signs €40m deal with the EIB

The candidate just hit its primary endpoint in a Phase II/III trial in soft tissue sarcoma (STS).

Latest news

More from news
Approximately 5 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Europe vs the US: New drug product approvals Europe vs the US: New drug product approvals

    Among the noteworthy approvals are Lartruvo (for the treatment of soft tissue sarcoma, approved in the EU and US), Rubraca (for the treatment of ovarian cancer, only approved in the US),

  • Case study: Treatment guidance Case study: Treatment guidance

    The Practical Guide was launched as part of a Takeda sponsored symposium at the British Sarcoma Group’s annual conference.

  • Pharma deals during February 2014 Pharma deals during February 2014

    Also, this month Merck &Co has handed back the rights to Ariad Pharmaceutical's ridaforolimus, a mTOR inhibitor in a phase III trial for advanced sarcoma.

  • Interview: Harvey Berger and Timothy Clackson, Ariad Interview: Harvey Berger and Timothy Clackson, Ariad

    And that was absolutely correct.”. After selling off investigational sarcoma treatment ridaforolimus to Merck &Co following an aborted collaboration attempt, ponatinib emerged as the front-runner in the company's pipeline

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics